Inhibitory Effects of Plant Trypsin Inhibitors Msti-94 and Msti-16 on Therioaphis Trifolii
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Self-Inhibitory Nature of Metabolic Networks and Its Alleviation Through Compartmentalization
ARTICLE Received 30 Oct 2016 | Accepted 23 May 2017 | Published 10 Jul 2017 DOI: 10.1038/ncomms16018 OPEN The self-inhibitory nature of metabolic networks and its alleviation through compartmentalization Mohammad Tauqeer Alam1,2, Viridiana Olin-Sandoval1,3, Anna Stincone1,w, Markus A. Keller1,4, Aleksej Zelezniak1,5,6, Ben F. Luisi1 & Markus Ralser1,5 Metabolites can inhibit the enzymes that generate them. To explore the general nature of metabolic self-inhibition, we surveyed enzymological data accrued from a century of experimentation and generated a genome-scale enzyme-inhibition network. Enzyme inhibition is often driven by essential metabolites, affects the majority of biochemical processes, and is executed by a structured network whose topological organization is reflecting chemical similarities that exist between metabolites. Most inhibitory interactions are competitive, emerge in the close neighbourhood of the inhibited enzymes, and result from structural similarities between substrate and inhibitors. Structural constraints also explain one-third of allosteric inhibitors, a finding rationalized by crystallographic analysis of allosterically inhibited L-lactate dehydrogenase. Our findings suggest that the primary cause of metabolic enzyme inhibition is not the evolution of regulatory metabolite–enzyme interactions, but a finite structural diversity prevalent within the metabolome. In eukaryotes, compartmentalization minimizes inevitable enzyme inhibition and alleviates constraints that self-inhibition places on metabolism. 1 Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK. 2 Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, UK. 3 Department of Food Science and Technology, Instituto Nacional de Ciencias Me´dicas y Nutricio´n Salvador Zubira´n, Vasco de Quiroga 15, Tlalpan, 14080 Mexico City, Mexico. -
Plant Protease Inhibitors: a Defense Strategy in Plants
Biotechnology and Molecular Biology Review Vol. 2 (3), pp. 068-085, August 2007 Available online at http://www.academicjournals.org/BMBR ISSN 1538-2273 © 2007 Academic Journals Standard Review Plant protease inhibitors: a defense strategy in plants Huma Habib and Khalid Majid Fazili* Department of Biotechnology, The University of Kashmir, P/O Naseembagh, Hazratbal, Srinagar -190006, Jammu and Kashmir, India. Accepted 7 July, 2007 Proteases, though essentially indispensable to the maintenance and survival of their host organisms, can be potentially damaging when overexpressed or present in higher concentrations, and their activities need to be correctly regulated. An important means of regulation involves modulation of their activities through interaction with substances, mostly proteins, called protease inhibitors. Some insects and many of the phytopathogenic microorganisms secrete extracellular enzymes and, in particular, enzymes causing proteolytic digestion of proteins, which play important roles in pathogenesis. Plants, however, have also developed mechanisms to fight these pathogenic organisms. One important line of defense that plants have to fight these pathogens is through various inhibitors that act against these proteolytic enzymes. These inhibitors are thus active in endogenous as well as exogenous defense systems. Protease inhibitors active against different mechanistic classes of proteases have been classified into different families on the basis of significant sequence similarities and structural relationships. Specific protease inhibitors are currently being overexpressed in certain transgenic plants to protect them against invaders. The current knowledge about plant protease inhibitors, their structure and their role in plant defense is briefly reviewed. Key words: Proteases, enzymes, protease inhibitors, serpins, cystatins, pathogens, defense. Table of content 1. -
Effect of Statins and ACE Inhibitors Alone and in Combination on Clinical Outcome in Patients with Coronary Heart Disease
Journal of Human Hypertension (2004) 18, 781–788 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease VG Athyros1, DP Mikhailidis3, AA Papageorgiou2, VI Bouloukos1, AN Pehlivanidis1, AN Symeonidis4 and M Elisaf5, for the GREACE Study Collaborative Group 1Atherosclerosis Unit, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece; 2Department of Clinical Biochemistry, Royal Free Hospital, Royal Free and University College Medical School, Pond Street, London, UK; 32nd Propedeutic Department of Internal Medicine, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece; 4Greek Society of General Practitioners, Thessaloniki, Greece; 5Department of Internal Medicine, Medical School, University of Ioannina, Greece We assessed the ‘synergy’ of statins and angiotensin- point in group A was 31%, (95% CI À48 to À6%, P ¼ 0.01) converting enzyme inhibitors (ACEI) in reducing vascu- in comparison to group B, 59% (95% CI À72 to À48%, lar events in patients with coronary heart disease (CHD). Po0.0001) to group C and 63% (95% CI À74 to À51%, The GREek Atorvastatin and CHD Evaluation (GREACE) Po0.0001) to group D. There was no significant Study, suggested that aggressive reduction of low difference in RRR between groups C and D (9%, CI density lipoprotein cholesterol to 2.59 mmol/l À27–10%, P ¼ 0.1). Other factors (eg the blood pressure) (o100 mg/dl) significantly reduces morbidity and mor- that can influence clinical outcome did not differ tality in CHD patients, in comparison to undertreated significantly between the four treatment groups. -
Effect of Aphis Craccivora Koch. Reared on Different Host Plants on the Biology of Cheilomenes Sexmaculata (Fabricius)
Journal of Biological Control, 30(1): 19-24, 2016 Research Article Effect of Aphis craccivora Koch. reared on different host plants on the biology of Cheilomenes sexmaculata (Fabricius) S. ROUTRAY*, K. V. HARI PRASAD and D. DEY1 Department of Entomology, S. V. Agricultural College, Tirupati - 517 501, ANGRAU, Andhra Pradesh, India. 1Department of Entomology, College of Agriculture, OUAT, Bhubaneswar-3, India. *Corresponding author E-mail: [email protected] ABSTRACT: Biology of Cheilomenes sexmaculata (Fabricius) was studied on aphids reared on different host plants. The total life cycle of C. sexmaculata ranged from 19.56 days to 27.87 days when aphids fed to this were reared on six different host plants viz., cowpea, groundnut, cotton, sunflower, greengram and blackgram. Adult male longevity varied from 11.00 to 14.00 days. Adult female longevity varied from 14.00 to 17.00 days. Shortest larval duration (6.75 days) was noticed on cowpea and longest larval duration (8.25 days) was noticed on groundnut. On cotton and sunflower 25 per cent larval mortality each were noticed. The head capsule width of first, second, third and fourth instar larvae of C. sexmaculata were 0.28±0.09 mm, 0.42±0.06 mm, 0.58±0.01 mm and 0.63±0.03 mm respectively when fed to aphids from nucleus culture. KEY WORDS: Aphis craccivora, Cheilomenes sexmaculata, host plants, larval duration, larval mortality (Article chronicle: Received: 12-12-2015; Revised: 04-02-2016; Accepted: 15-03-2016) INTRODUCTION MATERIALS AND METHODS Coccinellids are considered to be of great economic Nucleus cultures of aphids were maintained in a sus- importance and they have been successfully employed in ceptible cowpea cultivar (CO-702). -
A Contribution to the Aphid Fauna of Greece
Bulletin of Insectology 60 (1): 31-38, 2007 ISSN 1721-8861 A contribution to the aphid fauna of Greece 1,5 2 1,6 3 John A. TSITSIPIS , Nikos I. KATIS , John T. MARGARITOPOULOS , Dionyssios P. LYKOURESSIS , 4 1,7 1 3 Apostolos D. AVGELIS , Ioanna GARGALIANOU , Kostas D. ZARPAS , Dionyssios Ch. PERDIKIS , 2 Aristides PAPAPANAYOTOU 1Laboratory of Entomology and Agricultural Zoology, Department of Agriculture Crop Production and Rural Environment, University of Thessaly, Nea Ionia, Magnesia, Greece 2Laboratory of Plant Pathology, Department of Agriculture, Aristotle University of Thessaloniki, Greece 3Laboratory of Agricultural Zoology and Entomology, Agricultural University of Athens, Greece 4Plant Virology Laboratory, Plant Protection Institute of Heraklion, National Agricultural Research Foundation (N.AG.RE.F.), Heraklion, Crete, Greece 5Present address: Amfikleia, Fthiotida, Greece 6Present address: Institute of Technology and Management of Agricultural Ecosystems, Center for Research and Technology, Technology Park of Thessaly, Volos, Magnesia, Greece 7Present address: Department of Biology-Biotechnology, University of Thessaly, Larissa, Greece Abstract In the present study a list of the aphid species recorded in Greece is provided. The list includes records before 1992, which have been published in previous papers, as well as data from an almost ten-year survey using Rothamsted suction traps and Moericke traps. The recorded aphidofauna consisted of 301 species. The family Aphididae is represented by 13 subfamilies and 120 genera (300 species), while only one genus (1 species) belongs to Phylloxeridae. The aphid fauna is dominated by the subfamily Aphidi- nae (57.1 and 68.4 % of the total number of genera and species, respectively), especially the tribe Macrosiphini, and to a lesser extent the subfamily Eriosomatinae (12.6 and 8.3 % of the total number of genera and species, respectively). -
Biodiversity of the Natural Enemies of Aphids (Hemiptera: Aphididae) in Northwest Turkey
Phytoparasitica https://doi.org/10.1007/s12600-019-00781-8 Biodiversity of the natural enemies of aphids (Hemiptera: Aphididae) in Northwest Turkey Şahin Kök & Željko Tomanović & Zorica Nedeljković & Derya Şenal & İsmail Kasap Received: 25 April 2019 /Accepted: 19 December 2019 # Springer Nature B.V. 2020 Abstract In the present study, the natural enemies of (Hymenoptera), as well as eight other generalist natural aphids (Hemiptera: Aphididae) and their host plants in- enemies. In these interactions, a total of 37 aphid-natural cluding herbaceous plants, shrubs and trees were enemy associations–including 19 associations of analysed to reveal their biodiversity and disclose Acyrthosiphon pisum (Harris) with natural enemies, 16 tritrophic associations in different habitats of the South associations of Therioaphis trifolii (Monell) with natural Marmara region of northwest Turkey. As a result of field enemies and two associations of Aphis craccivora Koch surveys, 58 natural enemy species associated with 43 with natural enemies–were detected on Medicago sativa aphids on 58 different host plants were identified in the L. during the sampling period. Similarly, 12 associations region between March of 2017 and November of 2018. of Myzus cerasi (Fabricius) with natural enemies were In 173 tritrophic natural enemy-aphid-host plant interac- revealed on Prunus avium (L.), along with five associa- tions including association records new for Europe and tions of Brevicoryne brassicae (Linnaeus) with natural Turkey, there were 21 representatives of the family enemies (including mostly parasitoid individuals) on Coccinellidae (Coleoptera), 14 of the family Syrphidae Brassica oleracea L. Also in the study, reduviids of the (Diptera) and 15 of the subfamily Aphidiinae species Zelus renardii (Kolenati) are reported for the first time as new potential aphid biocontrol agents in Turkey. -
Kinase-Targeted Cancer Therapies: Progress, Challenges and Future Directions Khushwant S
Bhullar et al. Molecular Cancer (2018) 17:48 https://doi.org/10.1186/s12943-018-0804-2 REVIEW Open Access Kinase-targeted cancer therapies: progress, challenges and future directions Khushwant S. Bhullar1, Naiara Orrego Lagarón2, Eileen M. McGowan3, Indu Parmar4, Amitabh Jha5, Basil P. Hubbard1 and H. P. Vasantha Rupasinghe6,7* Abstract The human genome encodes 538 protein kinases that transfer a γ-phosphate group from ATP to serine, threonine, or tyrosine residues. Many of these kinases are associated with human cancer initiation and progression. The recent development of small-molecule kinase inhibitors for the treatment of diverse types of cancer has proven successful in clinical therapy. Significantly, protein kinases are the second most targeted group of drug targets, after the G-protein- coupled receptors. Since the development of the first protein kinase inhibitor, in the early 1980s, 37 kinase inhibitors have received FDA approval for treatment of malignancies such as breast and lung cancer. Furthermore, about 150 kinase-targeted drugs are in clinical phase trials, and many kinase-specific inhibitors are in the preclinical stage of drug development. Nevertheless, many factors confound the clinical efficacy of these molecules. Specific tumor genetics, tumor microenvironment, drug resistance, and pharmacogenomics determine how useful a compound will be in the treatment of a given cancer. This review provides an overview of kinase-targeted drug discovery and development in relation to oncology and highlights the challenges and future potential for kinase-targeted cancer therapies. Keywords: Kinases, Kinase inhibition, Small-molecule drugs, Cancer, Oncology Background Recent advances in our understanding of the fundamen- Kinases are enzymes that transfer a phosphate group to a tal molecular mechanisms underlying cancer cell signaling protein while phosphatases remove a phosphate group have elucidated a crucial role for kinases in the carcino- from protein. -
Identification of Novel Monoamine Oxidase B Inhibitors from Ligand Based Virtual Screening
Identification of novel monoamine oxidase B inhibitors from ligand based virtual screening A thesis submitted to Kent State University in partial Fulfillment of the requirements for the Degree of Master of Science By Mohammed Alaasam August, 2014 Thesis written by Mohammed Alaasam B.S., University of Baghdad, 2007 M.S., Kent State University, 2014 Approved by Werner Geldenhuys , Chair, Master’s Thesis Committee Richard Carroll , Member, Master’s Thesis Committee Prabodh Sadana , Member, Master’s Thesis Committee Eric Mintz , Director, School of Biomedical Sciences James Blank , Dean, College of Arts and Sciences ii Table of Contents List of figure ...................................................................................................................... vi List of tables ..................................................................................................................... xiii Acknowledgments............................................................................................................ xiv Chapter one: Introduction ............................................................................................... 1 1.1.Parkinson's disease ....................................................................................................... 1 1.2.Monoamine oxidase enzymes ....................................................................................... 7 1.3.Structures of MAO enzymes ....................................................................................... 12 1.4.Three dimentiona -
Evaluation of Squalestatine 1 As an Enzyme Inhibitor for Lowering Cholesterol
Evaluation of Squalestatine 1 as an Enzyme Inhibitor for Lowering Cholesterol By Samaneh Noor-Mohammadi Daniel-Frank Feze University Of Oklahoma College of Engineering School of Chemical, Biological and Materials Engineering Spring 2008 1 Table of Contents Abstract .......................................................................................................................................... 6 Introduction and Background ..................................................................................................... 7 Cholesterol ................................................................................................................................................ 7 Methods for Reducing Cholesterol Level .............................................................................................. 9 The Drug Model .......................................................................................................................... 11 Problem with Statin Drugs ...................................................................................................................... 11 Squalestatin 1 .......................................................................................................................................... 12 Drug Model ............................................................................................................................................. 14 Dosage .................................................................................................................................................... -
BIN Overlap Confirms Transcontinental Distribution of Pest Aphids (Hemiptera: Aphididae)
RESEARCH ARTICLE BIN overlap confirms transcontinental distribution of pest aphids (Hemiptera: Aphididae) 1,2 3 1,4 Muhammad Tayyib NaseemID , Muhammad AshfaqID *, Arif Muhammad Khan , Akhtar Rasool1,5, Muhammad Asif1, Paul D. N. Hebert3 1 National institute for Biotechnology and Genetic Engineering, Faisalabad, Pakistan, 2 Pakistan Institute of Engineering and Applied Sciences, Islamabad, Pakistan, 3 Centre for Biodiversity Genomics & Department of Integrative Biology, University of Guelph, Guelph, ON, Canada, 4 Department of Biotechnology, University of Sargodha, Sargodha, Pakistan, 5 Department of Zoology, University of Swat, Swat, Pakistan a1111111111 a1111111111 * [email protected] a1111111111 a1111111111 a1111111111 Abstract DNA barcoding is highly effective for identifying specimens once a reference sequence library is available for the species assemblage targeted for analysis. Despite the great need OPEN ACCESS for an improved capacity to identify the insect pests of crops, the use of DNA barcoding is Citation: Naseem MT, Ashfaq M, Khan AM, Rasool constrained by the lack of a well-parameterized reference library. The current study begins A, Asif M, Hebert PDN (2019) BIN overlap confirms to address this limitation by developing a DNA barcode reference library for the pest aphids transcontinental distribution of pest aphids of Pakistan. It also examines the affinities of these species with conspecific populations (Hemiptera: Aphididae). PLoS ONE 14(12): from other geographic regions based on both conventional taxonomy and Barcode Index e0220426. https://doi.org/10.1371/journal. pone.0220426 Numbers (BINs). A total of 809 aphids were collected from a range of plant species at sites across Pakistan. Morphological study and DNA barcoding allowed 774 specimens to be Editor: Feng ZHANG, Nanjing Agricultural University, CHINA identified to one of 42 species while the others were placed to a genus or subfamily. -
Therapeutic Class Overview Renin Inhibitors and Combinations
Therapeutic Class Overview Renin Inhibitors and Combinations INTRODUCTION Approximately 92.1 million American adults have at least one type of cardiovascular disease according to the 2017 American Heart Association Heart Disease and Stroke Statistics update. From 2004 to 2014, mortality associated with cardiovascular disease declined 25.3% (Benjamin et al, 2017). An estimated 85.7 million Americans or 34% of US adults aged ≥20 years have high blood pressure (BP). Hypertension is an independent risk factor for cardiovascular disease and increases the mortality risks of cardiovascular disease and other diseases (Benjamin et al, 2017). Lowering of BP has been shown to reduce the risk of fatal and nonfatal cardiovascular events including stroke and myocardial infarctions (MI) improving cardiovascular health and reducing cardiovascular risk also includes lipid control, diabetes management, smoking cessation, exercise, weight management, and limited sodium intake (Benjamin et al, 2017). Aliskiren (TEKTURNA®) is the only single entity direct renin inhibitor available in the United States (U.S.) and is Food and Drug Administration (FDA)-approved for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. Currently, only one combination renin inhibitor product is available in the US. This product combines the direct renin inhibitor, aliskiren, with a thiazide diuretic (TEKTURNA-HCT®) and is approved for hypertension. Studies have demonstrated that the combination of two inhibitors of the renin angiotensin system (RAS), including aliskiren, an angiotensin converting enzyme inhibitor (ACE-I) or an angiotensin II receptor blocker (ARB), provide no renal or cardiovascular benefits, and significant adverse events, particularly in patients with diabetes and/or renal insufficiency. -
Plant Serine Protease Inhibitors: Biotechnology Application in Agriculture and Molecular Farming
International Journal of Molecular Sciences Review Plant Serine Protease Inhibitors: Biotechnology Application in Agriculture and Molecular Farming Marina Clemente *, Mariana G. Corigliano, Sebastián A. Pariani, Edwin F. Sánchez-López, Valeria A. Sander and Víctor A. Ramos-Duarte Instituto Tecnológico Chascomús (INTECH), UNSAM-CONICET, Chascomús, Provincia de Buenos Aires B7130, Argentina; [email protected] (M.G.C.); [email protected] (S.A.P.); [email protected] (E.F.S.-L.); [email protected] (V.A.S.); [email protected] (V.A.R.-D.) * Correspondence: [email protected] Received: 12 January 2019; Accepted: 18 February 2019; Published: 17 March 2019 Abstract: The serine protease inhibitors (SPIs) are widely distributed in living organisms like bacteria, fungi, plants, and humans. The main function of SPIs as protease enzymes is to regulate the proteolytic activity. In plants, most of the studies of SPIs have been focused on their physiological role. The initial studies carried out in plants showed that SPIs participate in the regulation of endogenous proteolytic processes, as the regulation of proteases in seeds. Besides, it was observed that SPIs also participate in the regulation of cell death during plant development and senescence. On the other hand, plant SPIs have an important role in plant defense against pests and phytopathogenic microorganisms. In the last 20 years, several transgenic plants over-expressing SPIs have been produced and tested in order to achieve the increase of the resistance against pathogenic insects. Finally, in molecular farming, SPIs have been employed to minimize the proteolysis of recombinant proteins expressed in plants. The present review discusses the potential biotechnological applications of plant SPIs in the agriculture field.